James Kuo, Director at ImmunoPrecise Antibodies, holds 25.50K shares in ImmunoPrecise Antibodies (Ticker: IPA), holds 6.00M shares in Tryp Therapeutics Inc (Ticker: TSE:TRYP). Most recently, James Kuo Bought ― shares of ImmunoPrecise Antibodies on Mar 24, 2023 for an estimated value of 1.62K.